Twist Bioscience's Chief Legal: What Investors Need to Know
A senior executive at Twist BIOSCIENCE sold a sizable stake, sparking questions about insider activity. This article ...
Knowing when to revise your retirement strategy is key to staying on track. Learn the indicators that signal it's time for an adjustment.
21,255 articlesA senior executive at Twist BIOSCIENCE sold a sizable stake, sparking questions about insider activity. This article ...
A Fulton Financial director sold shares after the stock surged about 26%. This article breaks down what insider sales...
Richtech Robotics faced a dramatic sell-off last month as legal issues and a disappointing earnings report rattled in...
A recent SEC filing shows Marshall Investment Management adding a sizable stake to the TCW Flexible Income ETF (FLXR)...
A Ligand Pharmaceuticals insider recently sold 5,000 shares, triggering discussions about what insider moves signal f...
As AI reshapes how we search, socialize, and transact, two tech giants stand out: Alphabet and Meta Platforms. This a...
A reality TV win can change your life—and your finances—in an instant. This piece examines the financial implications...
Investors eye the Fennec Q1 2026 call to gauge milestones, cash runway, and potential catalysts. This guide breaks do...
IBM argues that data gravity keeps information in place. This investing piece explains why that matters, how AI reinf...
XYLD has delivered steady income, yet its upside is capped. This analysis details the hidden costs and current perfor...
Ethereum is showing real strength, rising sharply as momentum builds. In this guide, we break down the catalysts, ris...
A SpaceX public listing could ripple across technology, energy, and investing. Learn how NuScale Power stands to gain...